Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 443-449

  Emoto, Makoto ^a   Iwasaki, Hiroshi ^a   Kikuchi, Masahiro ^a   Shirakawa, Koichi ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SCREENING; CARCINOSARCOMA; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; METAPLASIA; MUELLERIAN DUCT; PRIORITY JOURNAL; PROTEIN FAMILY; UTERUS CARCINOMA; UTERUS SARCOMA;

EID: 0029942594     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0071     Document Type: Article

References (34)

1. Björklund, B., and Björklund, V. Antigenecity of pooled human malignant and normal tissues by cytoimmunological technique: Presence of an insoluble, heat-labile tumor antigen, Int. Arch. Allergy Appl. Immunol. 10, 153-184 (1957).
2. Björklund, B. On the nature and clinical use of tissue polypeptide antigen (TPA), Tumor Diagnostik 1, 9-20 (1980).
3. Björklund, B., and Björklund, V. Specificity and basis of the tissue polypeptide antigen, Cancer Detect. Prevent. 6, 41-50 (1983).
4. Mellerick, D. M., Osborn, M., and Weber, K. On the nature of serological tissue polypeptide antigen (TPA): Monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured carcinoma cells and TPA in human serum, Oncogene 5, 1007-1017 (1990).
5. Luthgens, M., and Schlegel, G. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in Oncologic therapy and surveillance, Cancer Detect. Prevent. 6, 51-59 (1983).
6. Pfaff, M., O'Connor, R., Vollmers, P., and Müller-Hermelink, H. K. Human monoclonal antibody against a tissue polypeptide antigen-related protein from a patient with a signet-ring cell carcinoma of the stomach, Cancer Res. 50, 5192-5198 (1990).
7. Maulard, C., Toubert, M. E., Chretien, Y., Delanian, S., Dufour, B., and Housset, M. Serum tissue popypeptide antigen (S-TPA) in bladder cancer as a tumor marker: A prospective study, Cancer 73, 394-398 (1994).
8. Panza, N., Pacilio, G., Campanella, L., Peruso, G., Battista, C., Amoriello, A., Utech, W., Vacca, C., and Lombardi, G. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen and beta-chain human chorionic gonadotoropin as serum markers of epithelial ovarian carcinoma, Cancer 61, 76-83 (1988).
9. Inoue, M., Inoue, Y., Hiramatsu, K., and Ueda, G. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors, Cancer 55, 2618-2623 (1985).
10. Ngan, H. Y., Cheng, G. T., Yeung, W. S., Wong, L. C., and Ma, H. K. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix, Gynecol. Oncol. 52, 63-68 (1994).
11. Ferdeghini, M., Gadducci, A., Prontera, C., Castellani, C., Annicchiarico, C., Gagetti, O., Facchini, V., and Bianchi, R. Determination of serum levels of different cytokeratins in patients with uterine malignan-cies, Anticancer Res. 14, 393-398 (1994).
12. Björklund, B., Björklund, V., Brunkener, M., Grönlund, H., and Back, M. The enigma of a human tumor marker: TPA revisited, in Human Tumor Markers (F. Climino, G. D. Birkmayer, J. V. Klavins, E. Pimental, and F. Salvatore, Eds.), de Gruyter, Berlin, pp. 169-180 (1987).
13. Chuang, J. T., Van Velden, D. J., and Graham, J. B. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus: Review of 49 cases, Obstet. Gynecol. 35, 769-780 (1970).
14. Williamson, E. O., and Christopherson, W. M. Malignant mixed Müllerian tumors of the uterus, Cancer 29, 585-592 (1972).
15. Norris, H. J., and Taylor, H. B. Mesenchymal tumors of the uterus: III. A clinical and pathologic study of 31 carcinosarcomas, Cancer 19, 1459-1465 (1966).
16. Norris, H. J., Roth, E., and Taylor, H. B. Mesenchymal tumors of the uterus. II. Clinical and pathologic study of 31 mixed mesodermal tumors, Obstet. Gynecol. 28, 57-63 (1966).
17. Kempson, R. L., and Bari, W. Uterine sarcomas: Classification, diagnosis, and prognosis, Hum. Pathol. 1, 331-349 (1970).
18. Salazar, O. M., Bonfiglio, T. A., Patten, S. F., Keller, B. E., Feldstein, M., Dunne, M. E., and Rudolph, J. Uterine sarcomas: Natural history, treatment and prognosis, Cancer 42(3), 1152-1160 (1978).
19. Barwick, K. W., and LiVolsi, V. A. Malignant mixed Müllerian tumors of the uterus: A clinicopathologic assessment of 34 cases, Am. J. Surg. Pathol. 3, 125-135 (1979).
20. Spanos, W. J., Wharton, J. T., Gomez, L., Fletcher, G. H., and Oswald, M. J. Malignant mixed müllerian tumors of the uterus, Cancer 53, 311-316 (1984).
21. George, E., Lillemoe, T. J., Twiggs, L. B., and Perrone, T. Malignant mixed mullerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: A comparative analysis of survival, Int. J. Gynecol. Pathol. 14, 39-44 (1995).
22. Bitterman, P., Chun, B. K., and Kurman, R. J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus, Am. J. Surg. Pathol. 14(4), 317-328 (1990).
23. van Haaften-Day, C., Russell, P., and Brammah-Carr, S. Two homologous mixed Müllerian tumor lines of the ovary and their characteristics, Cancer 65, 1753-1761 (1990).
24. Ramadan, M., and Goudie, R. B. Epithelial antigens in malignant mixed müllerian tumors of endometrium, J. Pathol. 148, 13-18 (1986).
25. Auerbach, H. E., LiVolsi, V. A., and Merino, M. J. Malignant mixed Müllerian tumors of the uterus: An immunohistochemical study, Int. J. Gynecol. Pathol. 7, 123-130 (1988).
26. Silverberg, S. G., Major, F. J., Blessing, J. A., Fetter, B., Askin, F. B., Liao, S. Y., and Miller, A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: A gynecologic oncology group pathologic study of 203 cases, Int. J. Gynecol. Pathol. 9, 1-19 (1990).
27. Meiss, J. M., and Lawrence, W. D. The immunohistochemical profiles of malignant mixed Müllerian tumor: Overlap with endometrial adenocarcinoma, Am. J. Clin. Pathol. 94, 1-7 (1990).
28. Masuda, A., Takeda, A., Fukami, H., Yamada, C., and Matsuyama, M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary: Carcinomatous cells are changeable to sarcomatous cells, Cancer 60, 2696-2703 (1987).
29. Emoto, M., Iwasaki, H., Kikuchi, M., Ishiguro, M., Kubota, T., Izumi, H., Shirakawa, K., and Kaneko, Y. Two cell lines established from mixed müllerian tumors of the uterus: Morphological, immunocytochemical, and cytogenetic analyses, Cancer 69, 1759-1768 (1992).
30. Emoto, M., Iwasaki, H., Kikuchi, M., and Shirakawa, K. Characteristics of cloned cells of mixed Müllerian tumor of the human uterus: Carcinoma cells showing myogenic differentiation in vitro, Cancer 71, 3065-3075 (1993).
31. Gorai, I., Doi, C., and Minaguchi, H. Establishment and characterization of carcinosarcoma cell line of the human uterus. Cancer 71, 775-786 (1993).
32. FIGO stages - 1988 Revision. Gynecol. Oncol. 35, 125-127 (1989). [Announcements]
33. Ueda, M., Sudo, N., Furuya, M., Arakawa, O., and Ikarashi, T. Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies, Acta Obstet. Gynaecol. Jpn. 37(11), 2361-2368 (1985).
34. Peters, W. A., III, Bagley, C. M., and Smith, M. R. CA-125: Use as a tumor marker with mixed mesodermal tumors of the female genital tract, Cancer 58, 2625-2627 (1986).